AbbVie (ABBV) EV to EBITDA (2013 - 2026)
AbbVie's (ABBV) EV to EBITDA stood at 17.67 in Q2 2026, up 6.2% from 16.63 a year earlier and up 10.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EV to EBITDA (2013 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EV to EBITDA came in at 16.85 as of Jun 30, 2026, up 7.3% year-over-year; for FY2025, it came in at 17.16, down 2.4% from FY2024.
- Across earlier years, EV to EBITDA came in at 17.59 in FY2024 (+44.6%), 12.16 in FY2023 (+16.9%), 10.41 in FY2022 (+19.8%) and 8.69 in FY2021 (-14.3%).
- Quarterly EV to EBITDA has ranged from 7.09 in Q3 2021 to 23.19 in Q3 2025 over the past five years.
- On a year-over-year basis, EV to EBITDA rose in six of the last eight quarters, with growth averaging 23.0%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 60.1% in Q2 2024, against a decline of 20.4% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 15.99 (Q1 2026), 17.09 (Q4 2025) and 23.19 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.67 |
| Mar 31, 2026 | 15.99 |
| Dec 31, 2025 | 17.09 |
| Sep 30, 2025 | 23.19 |
| Jun 30, 2025 | 16.63 |
| Mar 31, 2025 | 19.80 |
| Dec 31, 2024 | 17.61 |
| Sep 30, 2024 | 15.45 |
| Jun 30, 2024 | 14.02 |
| Mar 31, 2024 | 14.19 |
| Dec 31, 2023 | 12.19 |
| Sep 30, 2023 | 10.48 |
| Jun 30, 2023 | 8.76 |
| Mar 31, 2023 | 11.14 |
| Dec 31, 2022 | 10.42 |
| Sep 30, 2022 | 8.69 |
| Jun 30, 2022 | 10.19 |
| Mar 31, 2022 | 10.35 |
| Dec 31, 2021 | 8.69 |
| Sep 30, 2021 | 7.09 |
API Access
AbbVie EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();